T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs

NCT00021554 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

525

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Enfuvirtide

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]